Next Generation CAR-TCR Summit
Evvnt Promotion / evvnt
Archiv
22.02.2022 - 24.02.2022 Novotel London West, 1 Shortlands, W6 8DR London, Großbritannien
Time: 09:00 - 17:00
Kongressthemen
As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it's more important than ever to stay ahead of the curve. Stakeholders across oncology are now turning to next generation developments and innovations to create the therapies of tomorrow.
That's why CAR-TCR Europe has evolved into the Next Generation CAR-TCR Summit: your definitive platform focused on the 2.0, next generation innovations in cell therapies.
As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it's more important than ever to stay ahead of the curve. Stakeholders across oncology are now turning to next generation developments and innovations to create the therapies of tomorrow.
That's why CAR-TCR Europe has evolved into the Next Generation CAR-TCR Summit: your definitive platform focused on the 2.0, next generation innovations in cell therapies.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Leah Sibener Co-Founder, Head of Therapeutic Discovery 3T Biosciences, Blake Aftab Chief Scientific Officer Adicet Bio, Jak Knowles Chief Executive Officer Affini-T Therapeutics, Eric Von Hofe Chief Executive Officer AffyImmune and more.
Speakers: Leah Sibener Co-Founder, Head of Therapeutic Discovery 3T Biosciences, Blake Aftab Chief Scientific Officer Adicet Bio, Jak Knowles Chief Executive Officer Affini-T Therapeutics, Eric Von Hofe Chief Executive Officer AffyImmune and more.
Anfragen und Anmeldung:
https://go.evvnt.com/935698-2?pid=4832
Frau Ellie Saunders
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
